Sirnaomics Ltd. will ask shareholders at an EGM on 30 June 2026 to terminate its 2022 Restricted Share Unit (RSU) Scheme and 2022 Share Option Scheme and adopt updated 2026 versions for both programmes.
Key proposed changes • 2026 RSU Scheme – Aggregate limit, together with all other share schemes, capped at 10% of issued share capital on the adoption date—equivalent to 10.97 million shares, based on 109.72 million shares outstanding. – Vesting period normally at least 12 months, with limited exceptions. – Performance targets and claw-back provisions can be attached at the Board’s discretion. – 419,043 unallocated shares held by the existing trustee under the 2022 RSU Scheme will be reused to satisfy awards under the new plan.
• 2026 Share Option Scheme – Shares issuable under all new options, the new RSU plan and any other schemes are subject to the same 10% cap (10.97 million shares). – Options carry an exercise price not lower than the higher of the share’s last close, five-day average or par value. – Minimum 12-month vesting period, with identical exception framework to the RSU plan. – Outstanding options from the 2022 plan (726,115 options) remain valid; 1.19 million unallocated shares from the 2022 option pool will be used for future grants under the 2026 plan.
Status of existing 2022 plans • RSU Scheme: 903,200 RSUs granted; 142,026 cancelled, 277,017 lapsed and 7,862 remain unvested. • Share Option Scheme: 1.92 million options granted; 189,776 cancelled, 1.01 million lapsed and 726,115 remain outstanding.
Governance and timing No shareholder is deemed to have a material interest in the proposals, so no voting abstention is required. If approved, both 2026 schemes become effective upon adoption and receipt of Hong Kong Stock Exchange listing approval for new shares issued under the plans.
Comments